1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 1: Label frequencies of the training/validation and test setsa
Training/Validation Set Original Test Set before Protocol Review Final Test Set after Adjudication MR imaging brain without/with contrast 11,543 (68.4%) 1274 (67.9%) 1156 (6.2%) MR imaging brain for MS 2235 (13.2%) 242 (12.9%) 251 (13.4%) MR imaging tumor 963 (5.7%) 113 (6.0%) 149 (7.9%) MR imaging brain meningioma follow-up 653 (3.9%) 81 (4.3%) 117 (6.2%) MR imaging brain dedicated seizure with contrast 519 (3.1%) 65 (3.5%) 65 (3.5%) MR imaging stealth/Stryker/mask/presurgical planning 436 (2.6%) 43 (2.3%) 45 (2.4%) MR imaging for gamma knife, brain lab, and SRS 332 (2.0%) 41 (2.2%) 58 (3.1%) MR imaging cranial nerves III–VI without/with contrast 201 (1.2%) 17 (0.9%) 35 (1.9%) Total 16,882 1876 1876
↵a Data are No. (%).